Wells Fargo downgraded United Therapeutics (UTHR) to Equal Weight from Overweight with a price target of $314, down from $395.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UTHR:
- United Therapeutics upgraded to Neutral at BofA following selloff
- United Therapeutics upgraded to Neutral from Underperform at BofA
- United Therapeutics to present 10 posters, presentations at USHLT
- Buy Recommendation for United Therapeutics: Undervalued Potential in IPF Treatment with Tyvaso
- United Therapeutics price target lowered to $314 from $328 at BofA